Balaglitazone

DB12781InvestigationalSmall molecule

Balaglitazone has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor gamma
Curator reviewed
Formula / weight: C₂₀H₁₇N₃O₄S · 395.43 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyIETKPTYAGKZLKY-UHFFFAOYSA-NSMILESCN1C(COC2=CC=C(CC3SC(=O)NC3=O)C=C2)=NC2=CC=CC=C2C1=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

837Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Balaglitazone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.